What is the recommended dose of diphenhydramine (antihistamine) syrup per kilogram in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diphenhydramine Syrup Dosing in Pediatric Patients

The recommended dose of diphenhydramine syrup in pediatric patients is 1-2 mg/kg per dose, with a maximum single dose of 50 mg. 1

Dosing Guidelines

  • Diphenhydramine is typically dosed at 1-2 mg/kg per dose parenterally (IV/IM) in pediatric patients, with the same dosing range applicable to oral syrup formulations 1
  • Maximum initial dose should not exceed 50 mg regardless of weight 1
  • For acute hypersensitivity reactions or anaphylaxis, the recommended dose is 1-2 mg/kg or 25-50 mg/dose 1
  • For sleep disorders in children, a dose of 1.0 mg/kg at bedtime has been shown to be effective 2

Age-Based Considerations

  • For infants and young children: Use the lower end of the dosing range (1 mg/kg) 1
  • For older children and adolescents: The full 1-2 mg/kg dose can be used, not exceeding the 50 mg maximum 1
  • Weight-based dosing is preferred over age-based dosing to achieve more consistent plasma concentrations across different age groups 3

Administration Considerations

  • Diphenhydramine syrup formulation facilitates administration to children who cannot swallow tablets 4
  • Oral liquid formulations are more readily absorbed than tablets when used for acute allergic reactions 1
  • When used for anaphylaxis management, diphenhydramine should always be considered second-line therapy to epinephrine and should never be administered alone 1

Special Populations and Precautions

  • Reduce the dose by 50% in patients with renal impairment 4
  • Avoid use in patients with severe renal impairment (creatinine clearance <10 mL/min) 4
  • Avoid use in patients with severe hepatic impairment due to increased risk of sedation 4
  • Monitor for sedation and respiratory suppression, especially if using other sedative agents concurrently 1

Safety Considerations

  • Rapid IV administration may precipitate seizures; administer slowly when using parenteral routes 1
  • May cause paradoxical excitation or agitation in some pediatric patients 1
  • Doses above 1.0 g (1000 mg) are associated with severe symptoms including delirium, psychosis, seizures, and coma 5
  • Diphenhydramine has dose-dependent toxicity - moderate symptoms may occur above 300 mg, and severe symptoms above 1000 mg 5

Combination Therapy

  • When managing anaphylaxis, a combination of diphenhydramine and ranitidine (1 mg/kg) is superior to diphenhydramine alone 1
  • H1 antihistamines like diphenhydramine are considered second-line therapy to epinephrine in anaphylaxis 1

Remember that appropriate dosing in pediatric patients requires consideration of the child's weight, age, and organ maturity rather than simply administering a reduced adult dose 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hydroxyzine Dosing Considerations for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dose-dependent toxicity of diphenhydramine overdose.

Human & experimental toxicology, 2000

Research

Dosing considerations in the pediatric patient.

Clinical therapeutics, 1991

Research

Calculation of drug dosage and body surface area of children.

British journal of anaesthesia, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.